Squarepoint’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $587K | Buy |
161,192
+116,149
| +258% | +$423K | ﹤0.01% | 1820 |
|
2025
Q1 | $86.5K | Buy |
+45,043
| New | +$86.5K | ﹤0.01% | 2550 |
|
2024
Q4 | – | Sell |
-140,167
| Closed | -$185K | – | 2744 |
|
2024
Q3 | $185K | Buy |
140,167
+101,612
| +264% | +$134K | ﹤0.01% | 2197 |
|
2024
Q2 | $39.3K | Sell |
38,555
-216,109
| -85% | -$220K | ﹤0.01% | 2392 |
|
2024
Q1 | $466K | Buy |
254,664
+224,108
| +733% | +$410K | ﹤0.01% | 1706 |
|
2023
Q4 | $37.9K | Buy |
+30,556
| New | +$37.9K | ﹤0.01% | 2388 |
|
2022
Q3 | – | Sell |
-29,471
| Closed | -$10K | – | 2039 |
|
2022
Q2 | $10K | Sell |
29,471
-28,825
| -49% | -$9.78K | ﹤0.01% | 2040 |
|
2022
Q1 | $42K | Buy |
58,296
+32,044
| +122% | +$23.1K | ﹤0.01% | 2110 |
|
2021
Q4 | $59K | Buy |
+26,252
| New | +$59K | ﹤0.01% | 2393 |
|
2021
Q2 | – | Sell |
-238,876
| Closed | -$809K | – | 2577 |
|
2021
Q1 | $809K | Sell |
238,876
-179,904
| -43% | -$609K | ﹤0.01% | 1225 |
|
2020
Q4 | $1.17M | Sell |
418,780
-606,616
| -59% | -$1.7M | 0.01% | 978 |
|
2020
Q3 | $2.57M | Buy |
1,025,396
+931,780
| +995% | +$2.34M | 0.03% | 540 |
|
2020
Q2 | $1.27M | Sell |
93,616
-127,493
| -58% | -$1.73M | 0.02% | 807 |
|
2020
Q1 | $1.68M | Buy |
221,109
+107,989
| +95% | +$819K | 0.04% | 504 |
|
2019
Q4 | $715K | Sell |
113,120
-53,404
| -32% | -$338K | ﹤0.01% | 1515 |
|
2019
Q3 | $653K | Sell |
166,524
-118,521
| -42% | -$465K | 0.01% | 1432 |
|
2019
Q2 | $1.38M | Buy |
285,045
+174,503
| +158% | +$845K | 0.01% | 1054 |
|
2019
Q1 | $905K | Sell |
110,542
-47,463
| -30% | -$389K | 0.01% | 1149 |
|
2018
Q4 | $874K | Buy |
158,005
+73,142
| +86% | +$405K | 0.01% | 967 |
|
2018
Q3 | $749K | Buy |
84,863
+4,683
| +6% | +$41.3K | 0.01% | 1122 |
|
2018
Q2 | $800K | Buy |
80,180
+28,380
| +55% | +$283K | 0.01% | 979 |
|
2018
Q1 | $494K | Buy |
51,800
+13,996
| +37% | +$133K | 0.01% | 1091 |
|
2017
Q4 | $562K | Buy |
+37,804
| New | +$562K | 0.01% | 1129 |
|
2017
Q1 | – | Sell |
-18,462
| Closed | -$192K | – | 1488 |
|
2016
Q4 | $192K | Buy |
+18,462
| New | +$192K | 0.01% | 1457 |
|